Novavax, Inc. (LS:A2PKMZ) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David Mott Other companies: Mersana Therapeutics Inc (Director · Since at least Jun 27, 2017); Ardelyx, Inc. (Chairman · Since at least Jun 18, 2014); Enliven Therapeutics, Inc. (Director · Mar 11, 2020 – Jun 2, 2022 · Past); Nightstar Therapeutics PLC (Director · Jan 1, 2019 – Jun 7, 2019 · Past); Adaptimmune Therapeutics PLC (Director · Jan 1, 2016 – Jul 1, 2024 · Past); Epizyme Inc (Director · May 30, 2013 – Aug 12, 2022 · Past); Omthera Pharmaceuticals Inc (Director · Apr 11, 2013 – Jul 18, 2013 · Past); Tesaro Inc (Director · Jun 27, 2012 – Jan 22, 2019 · Past); Medimmune Inc (Vice Chair. of the Board, CEO, Director · Feb 23, 2006 – Jun 18, 2007 · Past) | Director · Since at least Jun 16, 2020 |
| Frederick W. Driscoll Other companies: Lite Strategy, Inc. (Chairperson, Non-Executive Director · Since at least Feb 22, 2018); Cellectar Biosciences, Inc. (Director · Since at least Apr 10, 2017); Invivyd, Inc. (Interim CFO · Oct 13, 2022 – Oct 13, 2022 · Past); ConforMIS Inc (INTERIM CFO & INTERIM TREAS · Oct 23, 2019 – Oct 23, 2019 · Past); Cue Biopharma, Inc. (Director · Jun 26, 2018 – Jan 2, 2025 · Past); ImmunityBio, Inc. (Director · Sep 18, 2017 – Aug 11, 2020 · Past); Flexion Therapeutics Inc (Chief Financial Officer · Feb 11, 2014 – Nov 19, 2021 · Past); Oncotelic Therapeutics Inc (Director · Jan 1, 2014 – Jun 1, 2016 · Past); Genelabs Technologies Inc (CEO/PRESIDENT · Nov 1, 2007 – Jan 7, 2009 · Past) | VP, CFO & Treasurer · Aug 24, 2009 – Mar 2, 2013 · Past |
| Gail K. Boudreaux Other companies: Target Corporation (Director · Since at least Sep 23, 2021); Elevance Health, Inc. (President and CEO · Since at least Nov 20, 2017); Zimmer Biomet Holdings, Inc. (Director · Dec 10, 2012 – Mar 31, 2021 · Past); Xcel Energy Inc. (Director · Mar 1, 2012 – Dec 28, 2017 · Past); UnitedHealth Group Incorporated (EVP & CEO, UnitedHealthcare · May 5, 2008 – Sep 23, 2014 · Past); Genzyme Corp (Director · May 25, 2006 – Apr 4, 2011 · Past) | Director · Jun 17, 2015 – Mar 16, 2017 · Past |
| Richard Rodgers Other companies: Opus Genetics, Inc. (Director · Since at least Dec 2, 2014); Ardelyx, Inc. (Director · Since at least Jun 18, 2014); Sagimet Biosciences Inc. - Series A (Director · Jul 13, 2023 – Jul 18, 2023 · Past); Tesaro Inc (Executive VP & CFO · Jun 27, 2012 – Mar 6, 2013 · Past); Abraxis BioScience Inc (Senior Vice President and CFO · Jul 9, 2009 – Jul 13, 2009 · Past); Mgi Pharma Inc (Sr. VP and Controller · Jul 15, 2006 – Jan 28, 2008 · Past) | Director · Since at least Oct 29, 2022 |
| Gregg Alton Other companies: Corcept Therapeutics Incorporated (Director · Since at least Mar 12, 2020); Lunai Bioworks Inc. (Director · Dec 27, 2019 – Jun 25, 2024 · Past); Eiger Biopharmaceuticals Inc (Director · Jan 29, 2014 – Jun 4, 2015 · Past); Sonoma Pharmaceuticals, Inc. (Director · Jan 16, 2008 – Oct 1, 2012 · Past); Gilead Sciences, Inc. (Chief Patient Officer · Jan 25, 2006 – Feb 15, 2019 · Past) | Director · Since at least Oct 31, 2020 |
| Charles Newton Other companies: Keros Therapeutics, Inc. (Director · Since at least Feb 26, 2026); Coherus Oncology, Inc. (Director · Since at least May 4, 2022); Lyell Immunopharma, Inc. (Chief Financial Officer · Since at least Jun 16, 2021); 2Seventy Bio Inc (Director · Mar 20, 2024 – May 13, 2025 · Past) | Director · Since at least Apr 25, 2025 |
| Barclay A Phillips Other companies: Immunic, Inc. (Director · Since at least Nov 18, 2019); G1 Therapeutics Inc (SVP & Chief Financial Officer · Nov 13, 2017 – Jan 2, 2019 · Past); Acorda Therapeutics Inc (Director · Feb 9, 2006 – Jun 13, 2008 · Past) | SVP, Chief Financial Officer · Jun 24, 2013 – Jul 31, 2017 · Past |
| Gregory F Covino Other companies: Tesaro Inc (SVP, CAO, PAO · Aug 13, 2018 – Jan 22, 2019 · Past); Biogen Inc. (VP, Chief Accounting Officer · May 1, 2012 – Mar 1, 2018 · Past); Hubbell Inc (Vice President, Controller · Dec 4, 2006 – Dec 6, 2007 · Past) | EVP, Chief Financial Officer · Nov 16, 2020 – Nov 16, 2020 · Past |
| Margaret G McGlynn Other companies: Amicus Therapeutics Inc (Director · Since at least Oct 28, 2009); Vertex Pharmaceuticals Incorporated (Director · May 12, 2011 – May 1, 2023 · Past); Air Products and Chemicals, Inc. (Director · Dec 31, 2005 – Sep 30, 2020 · Past) | Director · Since at least Dec 7, 2020 |
| Mark Casey Other companies: Mallinckrodt Inc (EVP & Chief Legal Officer · Feb 1, 2018 – Jun 16, 2022 · Past); Aceragen Inc. (Senior VP & General Counsel · Jun 29, 2015 – Jan 3, 2018 · Past); Hologic Inc (SVP, CAO, GC & Secretary · Jan 11, 2008 – Nov 18, 2014 · Past) | Executive Vice President, Chief Legal Officer · Since at least Dec 11, 2023 |
| Michael A McManus Jr Other companies: United States Antimony Corporation (Director · Since at least Aug 29, 2023); Eastern Company (the) (Director · May 20, 2015 – Dec 17, 2021 · Past); Misonix Inc (President and CEO, Director · Oct 4, 2006 – Jun 30, 2016 · Past) | Director · Feb 17, 2006 – Jun 16, 2022 · Past |
| Richard H. Douglas Other companies: MaxCyte, Inc. (Non-Executive Chairman · Since at least Jul 29, 2021); Aldeyra Therapeutics, Inc. (Chairman of the Board · Since at least Sep 13, 2016); Iomai Corp (Director · Jan 25, 2006 – Aug 5, 2008 · Past) | Director · Since at least Aug 6, 2010 |
| Stanley C Erck Other companies: MaxCyte, Inc. (Director · Since at least Jul 29, 2021); BioCryst Pharmaceuticals, Inc. (Director · Dec 22, 2008 – Nov 28, 2018 · Past); Iomai Corp (President & CEO, Director · Jan 25, 2006 – Aug 5, 2008 · Past) | President and CEO, Director · Jun 24, 2009 – Dec 14, 2022 · Past |
| Gary C. Evans Other companies: United States Antimony Corporation (CEO & Chairman · Since at least Dec 6, 2022); Magnum Hunter Resources Corp (Chairman and CEO, Director · Nov 5, 2009 – Mar 30, 2015 · Past) | Director · Jan 25, 2006 – Jun 17, 2021 · Past |
| James F Young Other companies: Medimmune Inc (President, R&D · Feb 3, 2006 – Jun 18, 2007 · Past); Iomai Corp (Director · Jan 25, 2006 – May 16, 2006 · Past) | Director · Apr 5, 2010 – Dec 24, 2024 · Past |
| James Patrick Kelly Other companies: Supernus Pharmaceuticals, Inc. (Executive Vice-President & CFO · Oct 12, 2020 – Feb 19, 2021 · Past); Vanda Pharmaceuticals Inc. (EVP & Chief Financial Officer · Jan 2, 2020 – Mar 2, 2020 · Past) | EVP, CFO and Treasurer · Since at least Aug 16, 2021 |
| Jeffrey Wayne Church Other companies: Imunon, Inc. (CFO · Since at least Jul 6, 2010); GenVec Inc (CFO · Jan 18, 2006 – Jan 18, 2006 · Past) | VP, CFO, Treasurer & Corp. Sec · Sep 5, 2006 – Mar 7, 2007 · Past |
| Rachel King Other companies: Fulcrum Therapeutics, Inc. (Board Member · Since at least Nov 12, 2024); Crescent Biopharma, Inc. (Director · Jan 7, 2016 – May 1, 2024 · Past) | Director · Since at least Oct 31, 2018 |
| Gregory M Glenn Other companies: Iomai Corp (Chief Scientific Officer · Jan 25, 2006 – Aug 5, 2008 · Past) | President, R&D · Jul 1, 2010 – Mar 6, 2023 · Past |
| Ian Watkins Other companies: Mallinckrodt Inc (See Remarks · Nov 11, 2020 – Jun 16, 2022 · Past) | Executive Vice President, Chief Human Resources Officer · Since at least Nov 5, 2026 |
| John C. Jacobs Other companies: Harmony Biosciences Holdings, Inc. (PRESIDENT, CEO, Director · Aug 18, 2020 – Aug 15, 2022 · Past) | President and Chief Executive Officer · Since at least Jan 23, 2023 |
| John Shiver Other companies: Icosavax Inc (Director · Jan 3, 2022 – Jun 6, 2023 · Past) | Director · Since at least Mar 10, 2025 |
| Dennis W Genge | VP, Treasurer,CFO · Feb 17, 2006 – Feb 17, 2006 · Past |
| Elaine O’Hara | Executive Vice President, Chief Strategy Officer · Since at least Mar 1, 2023 |
| Filip Dubovsky | President, R&D · Jun 16, 2023 – Jun 17, 2024 · Past |
| Jim Kelly | Executive Vice President, Chief Financial Officer and Treasurer · Since at least Jun 1, 2026 |
| Jim Robinson | VP, Technical & Quality Ops. · Aug 2, 2007 – Mar 5, 2009 · Past |
| John A Herrmann III | EVP, Chief Legal Officer · Jul 31, 2015 – Dec 14, 2023 · Past |
| John A Lambert | Director · Mar 7, 2007 – Apr 15, 2010 · Past |
| John O Marsh Jr | Director · Feb 17, 2006 – Mar 6, 2014 · Past |
| John Trizzino | President and COO · Jul 20, 2009 – Mar 7, 2025 · Past |
| Len F Stigliano | VP, CFO, Treasurer · Jul 2, 2007 – Jul 31, 2008 · Past |
| Mitchell J Kelly | Director · Feb 17, 2006 – Mar 2, 2006 · Past |
| Patricia Hall | Chief Accounting Officer · May 23, 2006 – Oct 30, 2006 · Past |
| Penny Heaton | VP & Chief Medical Officer · Aug 2, 2007 – Jul 2, 2009 · Past |
| Rajiv I Modi | Director · Mar 31, 2009 – Jun 16, 2015 · Past |
| Raymond Joseph Hage | Sr. VP. Commercial Operations · May 4, 2005 – Jul 1, 2009 · Past |
| Rick Crowley | Executive Vice President, Chief Operations Officer · Since at least Nov 4, 2026 |
| Rick Rodgers | Director · Since at least Jun 23, 2026 |
| Robert Walker | EVP, R&D · Since at least Mar 30, 2026 |
| Ruxandra Draghia-Akli | EVP, Research & Development · Since at least Nov 11, 2024 |
| Silvia Taylor | Executive Vice President, Chief Corporate Affairs Officer and Head of Novavax Sweden · Since at least Nov 5, 2026 |
| Timothy Jon Hahn | SVP, Manufacturing · Jun 10, 2013 – Mar 5, 2015 · Past |
| Troy Morgan | Senior Vice President, Deputy General Counsel & Chief Compliance Officer · Since at least Nov 5, 2026 |